Global Cell Culture Market

Cell Culture Market Size, Share, Growth Analysis, By Product (Consumables, Equipment), By Application (Biopharmaceutical Production, Diagnostics), By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2257 | Region: Global | Published Date: November, 2024
Pages: 208 | Tables: 96 | Figures: 71

Cell Culture Market Insights

Global Cell Culture Market size was valued at USD 28.2 billion in 2022 and is poised to grow from USD 32.01 billion in 2023 to USD 88.15 billion by 2031, growing at a CAGR of 13.50% during the forecast period (2024-2031).

Key trends in the global cell culture market are rising awareness of the application of cell culture and research, as well as financial development in the field of research and expansion in the field of cancer research. Growth in the industry is also aided by the anticipated rise in sophisticated cell culture technology. In vitro culture means isolating cells and growing them under controlled conditions without the help of a plant or an animal source. This artificial environment contains nutrients like appropriate pH, humidity, gases and temperature that enable the cells to grow and divide.

The extraction of cells from tissues prior to culture may be done using either enzyme-based or mechanical method. Established cell lines or cell strains are one of the options for cells to take care of cell culture. Various tools or equipment can be used in production of a cell culture. In addition to various chemicals, these devices are referred to as instruments. Cell cultures are produced using various chemicals too. Consumable refers to the fact that these compounds are used up during the procedure. A controlled physico-chemical environment, growth factors, hormones, gases, and a substrate or medium are all necessary for cell culture.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Cell Culture Market size was valued at USD 28.2 billion in 2022 and is poised to grow from USD 32.01 billion in 2023 to USD 88.15 billion by 2031, growing at a CAGR of 13.50% during the forecast period (2024-2031).

Trained with data till October 2023. Seriously competitive global cell culture market due to continuous innovation and technological advancement. Major players are focusing on strategic alliances, acquisitions as well as product development to expand their market share. Corning Incorporated, GE Healthcare, Merck KGaA, Thermo Fisher Scientific and Lonza Group are leading global companies supplying various cell culture products like medium, reagents among others. These companies are shaping the market by investing in biopharmaceuticals and cell-based research solutions. 'Thermo Fisher Scientific Inc. (US)  ', 'Danaher Corporation (US)  ', 'Merck KGAA (Germany)  ', 'Sartorius AG (Germany)  ', 'Corning Incorporated (US)  ', 'Fujifilm Holdings Corporation (Japan)  ', 'BD (Becton, Dickinson and Company) (US)  ', 'Eppendorf SE (Germany)  ', 'Lonza (Switzerland)  ', 'Getinge AB (Sweden)  ', 'Agilent Technologies, Inc. (US)  ', 'Himedia Laboratories (India)  ', 'Bio-Techne (US)  ', 'Miltenyi Biotec (Germany)  ', 'Stemcell Technologies (Canada)  ', 'Solida Biotech GmbH (Germany)  ', 'Caisson Labs Inc. (US)  ', 'Promocell GmbH (Germany)  ', 'Invivogen (US)  ', 'Pan-Biotech (Germany)  ', 'Cellexus (UK)  ', 'Meissner Filtration Products, Inc. (US)  ', 'Adolf Kühner AG (Switzerland)  ', 'Advancion Corporation (US)  ', 'Biospherix, Ltd. (US)'

Increased demand for biopharmaceuticals, such as cell-based therapies and monoclonal antibodies, is a result of the rising incidence of chronic diseases like diabetes, cancer, and autoimmune disorders. Cell culture is an indispensable instrument in medication manufacture since these biologics demand complex cell culture procedures for large-scale manufacturing, research, and development.

Rise of 3D Cell Culture Systems for Enhanced Drug Discovery: As they can more closely resemble in vivo settings, 3D cell culture methods are gradually taking the place of conventional 2D models. This trend is driving drug discovery, cancer research and toxicity testing which allows for improved efficacy in the development of therapies and accurate human tissue modeling.

North America, with its advanced healthcare system, huge efforts in research and development, and clustering of leading biotechnology and pharmaceutical firms, is today the world leader in global cell culture markets. Besides, there are many academic and research institutions that facilitate innovation and technology transfer in cell culture, thereby strengthening this region. North America's market leadership is further cemented by the region's advantageous legislative framework, significant financing for life sciences, and high adoption rates of cutting-edge technologies. North America is positioned as the major hub for cell culture breakthroughs and applications due to its highly qualified workforce, increased emphasis on personalized medicine, and use of regenerative medicines.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Cell Culture Market

Report ID: SQMIG35H2257

$5,300
BUY NOW GET FREE SAMPLE